About N-[3-[4-(4,4-difluorobut-3-enyl)-5-oxo-1,3,4-oxadiazol-2-yl]phenyl]acetamide
N-[3-[4-(4,4-difluorobut-3-enyl)-5-oxo-1,3,4-oxadiazol-2-yl]phenyl]acetamide (PubChem CID 139972600) has the molecular formula C14H13F2N3O3
and a molecular weight of 309.27 g/mol. Its IUPAC name is N-[3-[4-(4,4-difluorobut-3-enyl)-5-oxo-1,3,4-oxadiazol-2-yl]phenyl]acetamide.
Analyze N-[3-[4-(4,4-difluorobut-3-enyl)-5-oxo-1,3,4-oxadiazol-2-yl]phenyl]acetamide with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of N-[3-[4-(4,4-difluorobut-3-enyl)-5-oxo-1,3,4-oxadiazol-2-yl]phenyl]acetamide?
The IUPAC name of N-[3-[4-(4,4-difluorobut-3-enyl)-5-oxo-1,3,4-oxadiazol-2-yl]phenyl]acetamide (CID 139972600) is N-[3-[4-(4,4-difluorobut-3-enyl)-5-oxo-1,3,4-oxadiazol-2-yl]phenyl]acetamide.
What is the SMILES notation for N-[3-[4-(4,4-difluorobut-3-enyl)-5-oxo-1,3,4-oxadiazol-2-yl]phenyl]acetamide?
The canonical SMILES for N-[3-[4-(4,4-difluorobut-3-enyl)-5-oxo-1,3,4-oxadiazol-2-yl]phenyl]acetamide is CC(=O)Nc1cccc(-c2nn(CCC=C(F)F)c(=O)o2)c1.
What is the InChIKey of N-[3-[4-(4,4-difluorobut-3-enyl)-5-oxo-1,3,4-oxadiazol-2-yl]phenyl]acetamide?
The InChIKey is OFVHYHDYVQOWRQ-UHFFFAOYSA-N. The full InChI is InChI=1S/C14H13F2N3O3/c1-9(20)17-11-5-2-4-10(8-11)13-18-19(14(21)22-13)7-3-6-12(15)16/h2,4-6,8H,3,7H2,1H3,(H,17,20).
What are the key properties of N-[3-[4-(4,4-difluorobut-3-enyl)-5-oxo-1,3,4-oxadiazol-2-yl]phenyl]acetamide?
N-[3-[4-(4,4-difluorobut-3-enyl)-5-oxo-1,3,4-oxadiazol-2-yl]phenyl]acetamide has a molecular weight of 309.27 g/mol, XLogP of 2.63, 5 rotatable bonds, 1 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for N-[3-[4-(4,4-difluorobut-3-enyl)-5-oxo-1,3,4-oxadiazol-2-yl]phenyl]acetamide is sourced from PubChem (CID 139972600), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).